Lifeward (LFWD) Gross Profit Growth (1y) (2016 - 2026)
Lifeward (LFWD) Gross Profit Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.74% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 27.39% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -1.74% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.30% |
| 10 | Lifeward | 11.46 Mn | 37,305.54 | 1.34 Mn | -36.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.76% |
| Dec 31, 2025 | -41.00% |
| Sep 30, 2025 | 21.94% |
| Jun 30, 2025 | -8.92% |
| Mar 31, 2025 | 52.11% |
| Dec 31, 2024 | -24.52% |
| Sep 30, 2024 | 157.24% |
| Jun 30, 2024 | 378.65% |
| Mar 31, 2024 | 144.31% |
| Dec 31, 2023 | 263.00% |
| Sep 30, 2023 | 290.50% |
| Jun 30, 2023 | -22.79% |
| Mar 31, 2023 | 115.47% |
| Dec 31, 2022 | 104.56% |
| Sep 30, 2022 | -80.61% |
| Jun 30, 2022 | 2.61% |
| Mar 31, 2022 | -62.52% |
| Dec 31, 2021 | -18.16% |
| Sep 30, 2021 | 190.82% |
| Jun 30, 2021 | -28.86% |